Skip to content
Home/Companies/Biotech/AnaBios
AnaBios

AnaBios

Biotech·US·Active·10yr hold
Entry
2016
Hold
10yr
Status
Active

Who owns AnaBios?

AnaBios is currently owned by Principia SGR through Principia III - Health (2014 vintage), since 2016.

Hand-verified · updated 2026-07-26

Principia SGR
Investor
Principia SGR
Principia III - Health · 2014 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websiteanabios.com

More from Principia III - Health

Other portfolio companies in the same fund.

Comftech
Active
MedTechItaly· 2018
Compass Pathways
Compass Pathways
Exited 2020
BiotechUK· 2018
CrestOptics
CrestOptics
Active
MedTechItaly· 2018
Enterome
Enterome
Active
BiotechFrance· 2018
Gada
Gada
Active
MedTechItaly· 2018
Trifarma
Trifarma
Active
PharmaItaly· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track AnaBios

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy AnaBios?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on AnaBios.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue